(Q42640919)

English

Adenosine reduces postbypass transfusion requirements in humans after heart surgery

scientific article published on October 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Adenosine reduces postbypass transfusion requirements in humans after heart surgery (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

cardiac surgery

0 references

author name string

R M Mentzer

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

P S Rahko

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

C C Canver

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

P S Chopra

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

R B Love

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

T D Cook

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

M O Hegge

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

R D Lasley

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

0 references

publication date

1 October 1996

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Annals of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

224

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

523-9; discussion 529-30

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Adenosine spares platelets during cardiopulmonary bypass in man without causing systemic vasodilatation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cardiac effects of adenosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aprotinin protects platelets against the initial effect of cardiopulmonary bypass

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bleeding complications associated with cardiopulmonary bypass.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet Activation and Aggregation during Cardiopulmonary Bypass

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-aggregatory effects of physiological concentrations of adenosine in human whole blood as assessed by filtragometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural and synthetic antifibrinolytics in cardiac surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nucleoside transport inhibition and platelet aggregation in human blood: R75231 and its enantiomers, draflazine and R88016

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AHA president's letter

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salutary effects of exogenous adenosine administration on in vivo myocardial stunning

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limiting excessive postoperative blood transfusion after cardiac procedures. A review

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bleeding after cardiopulmonary bypass

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/00000658-199610000-00010

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42640919&oldid=1964360410"